Average Co-Inventor Count = 5.71
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Aktiengesellschaft (33 from 1,384 patents)
2. Bayer Intellectual Property Gmbh (14 from 721 patents)
3. Bayer Pharma Aktiengesellschaft (9 from 378 patents)
4. Bayer Schering Pharma Ag (7 from 192 patents)
5. Other (1 from 832,843 patents)
6. Bayer Aktiengesellschaft (1 from 12,160 patents)
64 patents:
1. 11311520 - Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors
2. 9962389 - 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
3. 9877954 - 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
4. 9790189 - Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
5. 9708293 - N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
6. 9669034 - 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
7. 9670161 - 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
8. 9650340 - 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
9. 9650361 - N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group
10. 9499492 - 4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
11. 9468642 - Imidazopyrazines
12. 9284317 - Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors
13. 9255100 - Substituted imidazopyridazines
14. 9212184 - 6-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitors
15. 9199999 - Substituted imidazopyrazines